USTEKINUMAB-TTWE
NDC 82009-160, ustekinumab-ttwe, injection, solution, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-160
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761373
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- USTEKINUMAB45 mg/.5mL
Pharmacologic classes
Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-160-11 | 82009016011 | 1 SYRINGE in 1 CARTON (82009-160-11) / .5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2b34392a-ecf6-41bd-8706-d4e9f0b25da8
Use it
Look up 82009-160 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.